Full Breakdown
Procter & Gamble Posts Strong Q1 2027 Results Amid a Split-Consumer Landscape
By Drooid · · How we work
Procter & Gamble Q1 2027 Earnings Beat Expectations
Procter & Gamble (P&G) announced fiscal first-quarter net income attributable to the company of $4.73 billion, or $1.97 per share, a slight decline from $4.75 billion and $1.95 per share a year earlier. Revenue and earnings both surpassed the consensus forecast compiled by LSEG, prompting the stock to climb more than 2 % in pre-market trading.
Consumer Trends and Bifurcated Market
Chief Financial Officer Andre Schulten described a “bifurcated economy,” noting that high-income shoppers are willing to upgrade to premium items such as a $30 shampoo, while low-income consumers focus on value packs and stretch existing brands. P&G has responded with promotional pricing, new pack sizes, and higher-priced innovations aimed at both segments.
Financial Highlights
- Overall volume growth: 2.4 % for the quarter, the only period of volume expansion in fiscal 2026.
- Fabric and home care (e.g., Tide, Febreze): volume up 4.3 %.
- Baby, feminine, family care and beauty divisions: each posted volume growth >2 %.
- Grooming (Gillette, Venus): volume down 0.4 %.
- Health care (Crest, Pepto-Bismol): volume down 2.9 %.
Outlook and Guidance
Chief Executive Officer Shailesh Jejurikar stated that P&G remains on track to meet its guidance despite “geopolitical and economic challenges.” For fiscal 2027, the company reaffirmed a core earnings-per-share target of $6.89 to $7.11 and raised its all-in sales-growth outlook to 2 %-4 %, up from the prior 1 %-3 % range. The revision reflects the recent acquisition of supplements brand Thorne, which closed on Oct. 1.
Implications for the Consumer Goods Sector
The results illustrate how large consumer-product firms are navigating divergent consumer spending patterns while leveraging acquisitions to broaden their portfolios. P&G’s ability to deliver modest growth and beat expectations may encourage peers to pursue similar dual-track pricing and product-innovation strategies as they confront ongoing economic uncertainty.
